Heery Christopher's Form 4 filing
Arcellx, Inc. (ACLX) · filed May 11, 2023
- Accession no.
- 0001209191-23-028720
- Filed
- May 11, 2023
- Trade date
- May 9-10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $121.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heery ChristopherCIK 0001789632 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 9, 2023 | Common Stock | SSaleDisposed | −500 | $45.00 | −$22,500 | 9,992 | Direct | |
| May 10, 2023 | Common Stock | SSaleDisposed | −2,197 | $45.18F2 | −$99,260.46 | 7,795 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 2,197 shares sold in the price range of $45.00 to $45.72 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.